Royal Philips Electronics N.V. And Biosense Webster, Inc. Collaborate To Improve Diagnosis And Care Of Irregular Heartbeats

ANDOVER, Mass. & DIAMOND BAR, Calif.--(BUSINESS WIRE)--Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Biosense Webster, Inc. announced today that they have signed an agreement to co-develop integrated products that will simplify complex procedures to diagnose and treat irregular heartbeats, also known as arrhythmias.
MORE ON THIS TOPIC